SPECT Imaging

GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a patient’s...

GE Healthcare introduced the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT (single photon emission computed tomography/computed tomography) system, the Optima NM/CT 640.

SNM's Clinical Trials Network (CTN) last week validated its 100th scanner, an important milestone in CTN's two-and-a-half year history. Scanner validation is an essential component of the CTN imaging site qualification program, which works with si...

Wide beam reconstruction (WBR) reduces both dose and image acquisition time by 50 percent for myocardial perfusion SPECT (MPI), according to a new study published in the March-April 2011 issue of the Journal of Nuclear Cardiology. WBR...

UltraSPECT has announced its distribution agreement with PharmaLogic for the sale of UltraSPECT’s cardiac and bone imaging applications. The...
Cardiolite vials
Lantheus Medical Imaging has entered into a new agreement with Fujifilm RI Pharma (FRI) to license and distribute Cardiolite (Kit for the Preparation of...
FDA Approval GE Healthcare's AdreView Nuclear Imaging SPECT systems
GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView (Iobenguane I 123 Injection), the first and only...
July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development (R&D) program with the St....
UltraSPECT has announced its distribution agreement with PharmaLogic for the sale of UltraSPECT’s cardiac and bone imaging
AdreView (Iobenguane I 123 Injection) is the first and only FDA approved molecular imaging agent to link nerve function in the heart to a...
The latest addition to GE Healthcare's Nuclear Medicine 600 series is a new performance SPECT/CT (single photon emission computed...
GE Healthcare announced the Brivo NM615 was cleared by the U.S. Food and Drug Administration (FDA) in January 2012.  An advanced...

Articles

Single photon emission computed tomography (SPECT) remains a well-entrenched imaging modality for nuclear myocardial perfusion imaging (MPI) more...
April 27, 2012 - More than 150 molecular imaging professionals gathered last week at the Society of Nuclear Medicine’s third Multimodality Cardiovascular...
There are currently three major trends in cardiac nuclear perfusion imaging technology: advances in detector hardware, improved software and new radiotracers....
Wide beam reconstruction (WBR) reduces both dose and image acquisition time by 50 percent for myocardial perfusion SPECT (MPI), according to a new study...

Video Center

Over the past decade in the United States, there has been growing interest in transradial artery...
11 weeks 1 day ago
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 3 days ago
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
19 weeks 1 day ago
EP lab, Tom De potter, depotter, angiography dose reduction
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available